If you liked this article you might like

Freeport-McMoRan, Apple Hospitality REIT, Abbott Laboratories: 'Mad Money' Lightning Round

Reversal of Fortunes: Cramer's 'Mad Money' Recap (Thursday 7/27/17)

Novartis Passes FDA Blood Cancer Panel 'With Flying Colors,' Gives Positive Read Through For Others

Landmark Novartis Immunotherapy Faces Crucial FDA Hearing Wednesday

FDA Decision on Novartis Gene Therapy Drug Could Benefit Kite Pharma